The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $20 million and $1 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority stake. It typically holds its investments for three to five years. Within automotive and transportation sectors, the firm seeks to hold its investments in for four to six years. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is
IPO Year: 2012
Exchange: NASDAQ
Website: carlyle.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/12/2024 | $42.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $55.00 | Buy | Redburn Atlantic |
| 8/6/2024 | $46.00 → $44.00 | Overweight → Neutral | JP Morgan |
| 1/19/2024 | $40.00 → $41.00 | Buy → Neutral | Citigroup |
| 1/4/2024 | $42.00 | Market Perform | TD Cowen |
| 11/29/2023 | $32.00 | Outperform → In-line | Evercore ISI |
| 10/5/2023 | Peer Perform | Wolfe Research | |
| 5/19/2023 | $40.00 | Buy | Citigroup |
| 3/2/2023 | $41.00 | Overweight | Barclays |
| 1/3/2023 | $36.00 | Outperform → Mkt Perform | Keefe Bruyette |
SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)
SC 13G/A - Carlyle Group Inc. (0001527166) (Subject)
SC 13G/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13G/A - Carlyle Group Inc. (0001527166) (Subject)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Reporting)
3 - Carlyle Group Inc. (0001527166) (Reporting)
4 - Carlyle Group Inc. (0001527166) (Reporting)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Reporting)
MCLEAN, Va., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for government healthcare agencies and the priority populations they serve, announced that Harish Nanda, the company's Chief Technology Officer, has been named a 2024 NVTC Tech100 Tech Executive honoree by the Northern Virginia Technology Council (NVTC). NVTC is one of the nation's largest technology councils, with a mission to establish the Northern Virginia region as a major global technology center. NVTC also recognized Acentra Health among Tech100 companies for driving innovation and supporting the region's economic growth.
Growth Driven By Solid Execution & Strength Across End Markets StandardAero (NYSE:SARO) announced results today for its third quarter ended September 30, 2024 ("Third Quarter 2024"). Third Quarter 2024 Highlights Revenue increased 13.2% year-over-year to $1,244.6 million Net Income was $16.4 million; Net Income Margin was 1.3% Adjusted EBITDA increased 26.0% year-over-year to $168.4 million Adjusted EBITDA Margin was 13.5%, an increase of 137 basis points compared to the prior year's quarter Capital expenditures were $25.3 million, reflecting continued investment in growth initiatives including the LEAP-1A/-1B program and the CFM56 Center of Excellence greenfield facility
MEMPHIS, Tenn., Nov. 12, 2024 /PRNewswire/ -- Sedgwick, a leading global provider of claims management, loss adjusting and technology-enabled business solutions, announced the closing of a significant minority investment in Sedgwick led by Altas Partners ("Altas"), a North American private equity firm, which was made public last month.Current investors, including funds managed by global investment firm Carlyle (NASDAQ:CG) and Stone Point Capital LLC, will remain as investors and continue to make significant new investments in the business, with Carlyle maintaining its control position in partnership with the investor group and the Sedgwick management team. Longtime investors CDPQ and Onex ar
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock. This dividend represents the new quarterly dividend rate for Baxter in anticipation of the divestiture of its Kidney Care business segment to Carlyle (NASDAQ:CG), which is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satisfaction of other closing conditions. Over its 93-year history, Baxter has co
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its third quarter ended September 30, 2024. Justin Plouffe, CGBD's Chief Executive Officer said, "We delivered consistent performance in the third quarter of 2024, capitalizing on increased new deal activity and the strength of our existing portfolio companies. With another strong quarter of originations, we benefited from access to the broader Carlyle Global Credit Platform, as we supplemented our core cash flow strategy with differentiated deal flow and specialty lending
Transaction strengthens balance sheet and liquidity with $1.5 billion of cash proceeds. Advance to provide an update on strategic priorities and financial objectives on November 14, 2024, in conjunction with third quarter 2024 results. Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket parts provider in North America that serves both professional installers and do-it-yourself customers, today announced the close of the sale of Worldpac, Inc. to global investment firm Carlyle (NASDAQ:CG). The sale agreement was announced on Aug. 22, 2024 with a transaction value of $1.5 billion. The company estimates net proceeds of approximately $1.2 billion after taxes and transacti
PLANO, Texas, Oct. 24, 2024 /PRNewswire/ -- CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, announced it has signed definitive agreements for a strategic investment from Patient Square Capital (Patient Square), a dedicated health care investment firm. Current shareholders, including investment funds affiliated with global investment firm Carlyle (NASDAQ:CG), TT Capital Partners, Sanaka Group, and CorroHealth management, will remain investors, with Patient Square and Carlyle sharing joint control of CorroHealth. "
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday November 20, 2024, for its fourth quarter and full year 2024. CCIF will host a conference call at 10:00 a.m. EDT on Thursday, November 21, 2024, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally manage
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, November 6, 2024 to announce its financial results for the third quarter ended September 30, 2024. A news release containing the quarterly results will be issued on Tuesday, November 5, 2024. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business dev
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (NASDAQ:CGBD) (the "Company") today announced that it has priced an underwritten public offering of $300 million in aggregate principal amount of 6.750% unsecured notes due 2030 (the "Notes"). The Notes will mature on February 18, 2030 and may be redeemed in whole or in part at the Company's option at the applicable redemption price. The offering is expected to close on October 18, 2024, subject to customary closing conditions. The Company intends to use the net proceeds from this offering to repay the Company's outstanding debt including the revolving credit facility, the Company's 4.750% unsecured notes and 4.
London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced the appointment of Robert (Bob) DeBenedetto as Managing Director – Clinical Co-Development. Bob brings to Abingworth over 30 years of experience in the life sciences industry and will be working on Clinical Co-Development deals and execution with new and existing Abingworth portfolio companies. He will be based in Abingworth's Menlo Park, CA, USA office. Prior to joining Abingworth, Bob was the Founder, President and CEO of SFJ Pharmaceuticals Inc. (CA, USA), an Abingworth portfolio company, where he
MCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett Barton as Senior Vice President (SVP) of Client Experience. In this newly created role, Barton will represent the voice of the client across multiple touchpoints to deliver an exceptional experience that supports continued growth for the company and elevates the Acentra Health brand. Barton brings over three decades of experience in healthcare technology and services supporting the public sector and health and human services market. He comes to Acentra Health from Gainwell
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova PartnersFunds will be used to build out Myricx Bio's proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform and advance its pipeline of NMTi-ADCs through clinical proof of concept targeting clinically validated tumour-associated antigensCompany to establish laboratory operations in London's biotech hub, and expand its management and R&D teamsMichael Bauer from Novo Holdings and Lucille Conroy from Abi
MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company's marketing strategy, creating data-driven frameworks to support the company's brand, content, digital, and product marketing programs. She reports to Acentra Health's Chief Growth Officer. "Heather brings a strong portfolio of success in helping companies elevate their brand and drive sustained growth throug
MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Grant Christie as Senior Vice President, Market Strategy and Solutions. A seasoned information technology solutions and services veteran with extensive experience in the public sector and commercial healthcare spaces, Christie will play a pivotal role in aligning Acentra Health's portfolio of products, solutions, and tech-enabled services to meet the needs and demands of the healthcare market and promote continued strong growth for the company.
MCLEAN, Va., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology services and solutions company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Daniel Hallenbeck as Vice President (VP) of Strategy and Strategic Partnerships. A nationally recognized expert in Medicaid Enterprise Systems and a former New York State (NYS) Medicaid Chief Technology Officer (CTO), Hallenbeck will serve as an integral member of the Acentra Health Leadership Team, supporting the Chief Strategy Officer in the development and execution of the company's strategy around value creation, digital health, and mergers and acquisi
NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt
NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Carlyle Credit Income Fund (the "Fund" or "CCIF") (NYSE:CCIF) today is pleased to announce the early completion of the initial transition plan following the appointment of Carlyle Global Credit Investment Management L.L.C., an affiliate of Carlyle (together with their affiliates, "Carlyle"), as CCIF's external investment adviser. The transition plan included the following steps: Carlyle completed the $10 million one-time Payment to the Fund's shareholders of record on July 14, 2023;Carlyle completed the tender offer to purchase $25 mill
Company Changes Investment Mandate to Focus on Investing in CLOsWill Trade Under New Stock Ticker 'CCIF'Carlyle Completes Previously-Announced $10 Million One-Time Payment to Company Shareholders of RecordCarlyle Will Launch $25 Million Tender Offer for Company Shares on July 18, 2023Company Board of Trustees Declares July Dividend of $0.0551NEW YORK, July 17, 2023 /PRNewswire/ -- Vertical Capital Income Fund (NYSE: VCIF) ("VCIF" or the "Company") today announced that it has changed its corporate name from VCIF to Carlyle Credit Income Fund ("CCIF") in connection with the closing of the previously announced transaction with global investment firm, Carlyle (NYSE:CG), and will begin trading un
FGH Parent, L.P. ("Fortitude Re"), today announced the opening of its Tokyo Representative Office and appointment of Hajime Kawafuji as its Chief Representative. Mr. Kawafuji is a leader in the Japanese business community, with a broad range of investing and advisory experience across several industries. He joins Fortitude Re from global investment firm Carlyle (NASDAQ:CG), where he was a senior member of the Japan buyout advisory team. Prior to Carlyle, Mr. Kawafuji spent more than a decade at Nomura in its Investment Banking division. Mr. Kawafuji will partner with Leonard Lin, Head of Asia at Fortitude Re, to deliver the continued high-quality execution and tailored solutions that clie
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock. This dividend represents the new quarterly dividend rate for Baxter in anticipation of the divestiture of its Kidney Care business segment to Carlyle (NASDAQ:CG), which is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satisfaction of other closing conditions. Over its 93-year history, Baxter has co
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its third quarter ended September 30, 2024. Justin Plouffe, CGBD's Chief Executive Officer said, "We delivered consistent performance in the third quarter of 2024, capitalizing on increased new deal activity and the strength of our existing portfolio companies. With another strong quarter of originations, we benefited from access to the broader Carlyle Global Credit Platform, as we supplemented our core cash flow strategy with differentiated deal flow and specialty lending
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday November 20, 2024, for its fourth quarter and full year 2024. CCIF will host a conference call at 10:00 a.m. EDT on Thursday, November 21, 2024, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally manage
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, November 6, 2024 to announce its financial results for the third quarter ended September 30, 2024. A news release containing the quarterly results will be issued on Tuesday, November 5, 2024. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business dev
Sale simplifies Advance's enterprise structure and sharpens focus on the blended box business Net proceeds to be used primarily to strengthen balance sheet and invest in the business Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket parts provider in North America that serves both professional installer and do-it-yourself customers, announced that it has entered into a definitive agreement to sell Worldpac, Inc., an automotive parts wholesale distribution business, to funds managed by global investment firm Carlyle (NASDAQ:CG) for $1.5 billion in cash. The transaction is expected to close before the end of the year. "We are pleased to announce the sale of the World
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its second quarter ended June 30, 2024. Justin Plouffe, CGBD's Chief Executive Officer said, "Our core middle-market strategy and active approach to portfolio management continued to drive strong performance in the second quarter of 2024, as we maintained a dynamic approach to origination in an increasingly competitive market. With increased volume during the quarter, we capitalized on attractive origination opportunities, and we see the potential for increased deal ac
Provides meaningful scale and diversity to CGBD through addition of a Carlyle-managed portfolio Carlyle to exchange CGBD convertible preferred stock for CGBD common stock at NAV, eliminating current 5% – 8% preferred stock dilution overhang Advisors agreed to cover transaction costs in certain circumstances up to a total cap of $5 million NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD), a business development company focused on directly-originated lending to sponsor-backed U.S. middle market companies, has entered into a definitive agreement to acquire Carly
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday August 21, 2024, for its third quarter of 2024. CCIF will host a conference call at 10:00 a.m. EDT on Thursday, August 22, 2024, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end fun
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 10:00 a.m. EST on Monday, August 5, 2024 to announce its financial results for the second quarter ended June 30, 2024. A news release containing the quarterly results will be issued on Monday, August 5, 2024. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development com
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CSL" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2024. Justin Plouffe, CSL's Chief Executive Officer said, "Consistent with prior quarters, our portfolio continued to deliver steady income and a stable NAV during the first quarter of 2024. It has always been our goal to drive performance with a consistent approach to direct lending anchored in disciplined credit selection and conservative portfolio management. We remain focused on our core middle market strategy and benefit from the differ
Ares Management Corp. (NYSE:ARES) and HPS Investment Partners are spearheading a $3 billion credit facility to finance Carlyle Group Inc.’s (NASDAQ:CG) potential acquisition of Baxter International Inc.’s (NYSE:BAX) kidney-care division. This debt package includes a $2.5 billion unitranche loan and a $450 million revolver. Oaktree Capital Management is also involved in the financing, and smaller lenders may participate after signing. Also Read: Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System. The financing terms suggest an interest rate five percentage points above the Secured Overnight Financing Rate, placing the division Vantive’s leverage at 4.2
https://www.bloomberg.com/news/articles/2024-07-23/ares-hps-line-up-3-billion-debt-for-carlyle-s-baxter-unit-bid?sref=y3YMCJ4e
Directors Robert Langer and Stephen Berenson will also retire from the Board.
Barclays analyst Benjamin Budish maintains Carlyle Group (NASDAQ:CG) with a Overweight and raises the price target from $47 to $51.
On CNBC's “Halftime Report Final Trades,” Kevin Simpson of Capital Wealth Planning said profits, net margins of Caterpillar Inc. (NYSE:CAT) are at all-time highs. On June 12, Caterpillar raised its dividend and increased its share repurchase program. The Board of Directors voted to increase the quarterly dividend by 11 cents, an 8% rise to $1.41 per share, payable on August 20 2024, to shareholders of record as of July 22, 2024. Additionally, Caterpillar added $20 billion to its current share repurchase authorization, allowing for up to $21.8 billion in stock buybacks. Shannon Saccocia of NB Private Wealth named iShares U.S. Real Estate ETF (NYSE:IYR) as her final trade. Don't forge
Discover Financial Services (NYSE:DFS) shares are trading higher today after the company reported better-than-expected second-quarter EPS results yesterday. The company reported GAAP earnings of $6.06 per share, beating the estimate of $3.07 per share, and quarterly Net Interest Income (NII) of $3.524 billion. RBC Capital Markets analyst Jon G. Arfstrom says the stock’s performance (Sector Perform, with a $140 price target) is likely to be influenced primarily by the pending merger with Capital One Financial Corporation (NYSE:COF), with the expectation that the acquisition will eventually be completed. Concurrently, Discover is progressing independently by addressing regulatory and
https://www.bloomberg.com/news/articles/2024-07-16/blackstone-cvc-weigh-bids-for-carlyle-s-standardaero?srnd=phx-deals Blackstone Inc. and CVC Capital Partners Plc are among the private equity firms weighing bids for StandardAero that could value the aircraft maintenance services provider at $10 billion or more including debt, people with knowledge of the matter said.Veritas Capital has also expressed initial interest in acquiring the Carlyle Group Inc.-backed business, according to the people, who asked not to be identified discussing confidential information. Carlyle is expected to ask for first-round bids as soon as this week and other bidders could still emerge, they said. It's possible
Wells Fargo initiated coverage of Carlyle Group with a rating of Equal Weight and set a new price target of $42.00
Redburn Atlantic initiated coverage of Carlyle Group with a rating of Buy and set a new price target of $55.00
JP Morgan downgraded Carlyle Group from Overweight to Neutral and set a new price target of $44.00 from $46.00 previously
Citigroup downgraded Carlyle Group from Buy to Neutral and set a new price target of $41.00 from $40.00 previously
TD Cowen initiated coverage of Carlyle Group with a rating of Market Perform and set a new price target of $42.00
Evercore ISI downgraded Carlyle Group from Outperform to In-line and set a new price target of $32.00
Wolfe Research initiated coverage of Carlyle Group with a rating of Peer Perform
Citigroup initiated coverage of Carlyle Group with a rating of Buy and set a new price target of $40.00
Barclays initiated coverage of Carlyle Group with a rating of Overweight and set a new price target of $41.00
Keefe Bruyette downgraded Carlyle Group from Outperform to Mkt Perform and set a new price target of $36.00
13F-HR - Carlyle Group Inc. (0001527166) (Filer)
10-Q - Carlyle Group Inc. (0001527166) (Filer)
N-PX - Carlyle Group Inc. (0001527166) (Filer)
13F-HR - Carlyle Group Inc. (0001527166) (Filer)
S-8 - Carlyle Group Inc. (0001527166) (Filer)
10-Q - Carlyle Group Inc. (0001527166) (Filer)
8-K - Carlyle Group Inc. (0001527166) (Filer)
8-K - Carlyle Group Inc. (0001527166) (Filer)
10-Q - Carlyle Group Inc. (0001527166) (Filer)
13F-HR - Carlyle Group Inc. (0001527166) (Filer)